Aims and Scope
The journal encourages innovative research and expert review of information at the forefront of molecular interactions at the interface of Chemistry, Cell Biology and Immunology. Also, the Editor seeks to publish original information leading to evolving advances and theories in these fields and studies of the therapeutic efficacy of promising drugs sustained on evidence. Furthermore, it provides insight into the new and emerging progress and models in these areas, as well as in associated technologies to drug discovery.
JDRD is mostly interested in publishing manuscripts that report original research, assessments among different tools and methods used for the discovery of new drug and biologic (particularly mAb) targets. Likewise, seeks studies that analyse different industry pathways from the discovery up to the launch of the product. Correspondingly, it concentrates on reviews on Pharmacology, Pharmacokinetics, Toxicology and their translational aspects interesting to an international audience. Similarly, JDRD pursues accounts of research in Biopharmaceuticals and biotechnical challenges in ensuring drug action.
JDRD aims at an audience of Chemists, Chemical Engineers, Biologists, Scientists, and Oncologists working in R&D of drugs and biologics. Also, it may prove appealing to Scientists in Drug Design and Discovery, those occupied on the development of new drugs and biologics committed to the most updated and meaningful progress in Pharmacological Engineering and Biotechnology.
Core areas of interest of JDRD include vital improvements that result in a better understanding of molecular mechanisms, gene regulation in normal and diseased cells as well as susceptibility and outcome to oncogenic agents. Similarly, the journal has interest on the worth resulting from the research and application of multiple disciplines converging to medication innovation.
The journal pursues contributions which prioritize merit, originality, practical worth, reduction to practice, accuracy, and appeal to the readership. Those working in the drug discovery and development field, researchers engaged at Immunotherapy, Pharmaceutics, Computational Drug-target Analysis, Pre-clinical and Clinical Pharmacology, studying medication-hormone receptor-immune system interactions, natural products evaluation, Pharmacokinetics, are contributors of articles to JDRD.
All manuscripts in JDRD will be comprehensively peer-reviewed by independent professionals following an initial assessment by the Editors to assure their scientific sharpness, innovation, and significance.
Call for submissions
The Journal of Drug Research and Development publishes articles of original, interdisciplinary, nature. The Editor actively encourages the most diverse aspects and knowledge that contribute to the disciplines that meet in the Research on Pharmacology and Drug Discovery. Similarly, JDRD is interested in research articles on Discovery, design and optimization of new compounds, and innovative techniques on Drug and Biologic delivery, among other disciplines. Moreover, authors may submit reviews (by invitation from the Editor) and letters to the Editor.
Subjects covered by The Journal of Drug Research and Development
• Compound Management
• Cardiovascular biology
• Computational Chemistry
• Chemo informatics
• Molecular Modelling
• Molecular Docking
• Clinical Pharmacology
• Computer-assisted Drug Design
• Drug-drug & Drug-Chemical Interactions
• New Molecular Entity
• Orphan Drug
• Pharmaceutical Chemistry
• Pharmaceutical Toxicology
• High throughput Screening
• Medicinal Chemistry
• Structure-activity Relationships (SAR)
• Quantitative structure-activity Relationship
• Simcyp Simulator
• Synthetic Chemistry
• Therapeutic Window
• Physiologically-based pharmacokinetic modelling